Andrew Oxtoby

Aimmune Therapeutics’ PALFORZIA the first-ever treatment option approved for peanut allergy in the EU

(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis…

3 years ago

Aimmune Therapeutics now a Nestlé Health Science company

(PRESS RELEASE) VEVEY, 14-Oct-2020 — /EuropaWire/ — Nestlé has successfully closed the acquisition of biopharmaceutical company, Aimmune Therapeutics, Inc. (Nasdaq:…

4 years ago